Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,744 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in the primary outcome in Ebola vaccine trial--Authors' reply.
Kieny MP, Longini IM, Henao-Restrepo AM, Watson CH, Egger M, Edmunds WJ. Kieny MP, et al. Among authors: egger m. Lancet. 2016 Apr 9;387(10027):1509-1510. doi: 10.1016/S0140-6736(16)00686-3. Epub 2016 Apr 7. Lancet. 2016. PMID: 27115974 No abstract available.
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.
Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A. Bohlius J, et al. Among authors: egger m. Lancet. 2009 May 2;373(9674):1532-42. doi: 10.1016/S0140-6736(09)60502-X. Lancet. 2009. PMID: 19410717
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, Kone S, Kuisma E, Levine MM, Mandal S, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Watson CH, Kéïta S, Kieny MP, Røttingen JA. Henao-Restrepo AM, et al. Among authors: egger m. Lancet. 2015 Aug 29;386(9996):857-66. doi: 10.1016/S0140-6736(15)61117-5. Epub 2015 Aug 3. Lancet. 2015. PMID: 26248676 Clinical Trial.
Ebola vaccination - Authors' reply.
Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM; study steering group. Longini IM, et al. Among authors: egger m. Lancet. 2015 Dec 19;386(10012):2480. doi: 10.1016/S0140-6736(15)00951-4. Epub 2015 Dec 18. Lancet. 2015. PMID: 26738716 No abstract available.
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP. Henao-Restrepo AM, et al. Among authors: egger m. Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Lancet. 2017. PMID: 28017403 Free PMC article. Clinical Trial.
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
ART-LINC of IeDEA Study Group; Keiser O, Tweya H, Boulle A, Braitstein P, Schecter M, Brinkhof MW, Dabis F, Tuboi S, Sprinz E, Pujades-Rodriguez M, Calmy A, Kumarasamy N, Nash D, Jahn A, MacPhail P, Lüthy R, Wood R, Egger M. ART-LINC of IeDEA Study Group, et al. Among authors: egger m. AIDS. 2009 Sep 10;23(14):1867-74. doi: 10.1097/QAD.0b013e32832e05b2. AIDS. 2009. PMID: 19531928 Free PMC article.
1,744 results